TrialAtherosclerosis2023

Eicosapentaenoic and docosahexaenoic acid supplementation and coronary artery calcium progression in patients with coronary artery disease: A secondary analysis of a randomized trial.

Essa Hariri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.